Drugs / Rob 803
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00525213 Comparator | Oct 2007 → Aug 2009 | rheumatoid arthritis | OxyPharma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rob 803 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00525213 ↗ |
| Route | Oral | “Rob 803 administered orally once daily” NCT00525213 ↗ |